Saama Unveils New Capabilities for Life Science Analytics Cloud
Saama Technologies, Inc., a data analytics company, launched three new machine learning-based capabilities that add to the existing functionality of its Life Science Analytics Cloud (LSAC). Saama announced the addition of these programs infused with artificial intelligence (AI)-Virtual Assistant/AI, Operational and Financial Risk Mitigation, and Drug Efficacy and Patient Safety Analytics-during the 10th Annual Summit for Clinical Ops Executives (SCOPE) in Orlando.
Read the full release here.
Key Phase 3 Trial Results Lead to FDA Approval of Fabhalta for Paroxysmal Nocturnal Hemoglobinuria
December 6th 2023Clinical trials demonstrated superiority of Fabhalta to anti-C5s in hemoglobin improvement in the absence of transfusions and transfusion avoidance rate, showing clinically meaningful hemoglobin-level increases without the need for blood transfusions in patients with paroxysmal nocturnal hemoglobinuria.
‘Hypothesis-Free’: Getting Proactive About Signal Detection
December 5th 2023Elizabeth Smalley, director of product management, data, and analytics at ArisGlobal speaks about her work at the software company in supporting the efforts of life sciences clinical and pharmacovigilance teams in signal detection.
